Comparison of bronchoalveolar lavage fluid mNGS and sputum culture in the clinical application of severe pneumonia
Frontiers in Cellular and Infection Microbiology · 2025
DOI: 10.3389/fcimb.2025.1593818 ↗Kurz gefasst
Vergleichsstudie in der Zeitschrift Frontiers in Cellular and Infection Microbiology, 2025. Verfasst von Na Gao und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Yulin Hospital, Yulin, Shanxi, Chin…. Hauptthemen laut MEDLINE: Sputum, Bronchoalveolar Lavage Fluid, Pneumonia. Die Arbeit wurde bisher 10-mal zitiert (Crossref) und nennt 32 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Objective
The purpose of this study is to compare the clinical application value of bronchoalveolar lavage fluid (BALF) mNGS and sputum culture in severe pulmonary infections, and to provide guidance for clinicians in selecting the appropriate testing method.
Methods
This study collected 105 patients diagnosed with severe pneumonia, of which 55 patients who underwent BALF mNGS. We compared the pathogen detection rates, length of stay and mortality rate, treatment, and pathogen species between BALF mNGS group and sputum culture group.
Results
The pathogen detection rate in BALF mNGS group was significantly higher than that in sputum culture group ( P <0.0001). The length of hospital stay in the BALF mNGS group was shorter than that in the sputum group ( P =0.0093). There was no statistically significant difference in mortality rate between the two groups ( P =0.26). However, BALF mNGS group had a lower antibiotic usage rate than the sputum culture group ( P =0.0491). According to the mNGS results, initial antipathogenic treatment was modified in 67.27% of patients. In BALF mNGS group, the main pathogens detected included Mycoplasma pneumoniae , Mycobacterium tuberculosis (MTB) and Haemophilus influenzae (HI). The sputum culture group mainly included: MTB, HI.
Conclusion
BALF mNGS effectively and rapidly identifies pathogens, helping doctors quickly diagnose severe pneumonia pathogens. Combined with the patient’s medical history, laboratory results and imaging, clinical doctors can adjust the patient’s treatment plan in time. This has potential advantages in improving the cure rate of severe pneumonia patients, reducing the length of hospital stay, and improving the prognosis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Yulin Hospital, Yulin, Shanxi, China.
- Department of Allergy, The First Affiliated Hospital of Xi'an Jiaotong University, Yulin Hospital, Yulin, Shanxi, China.
- Department of Respiratory and Critical Care Medicine, The First Affiliated Hospital of Xi'an Jiaotong University, Xi'an, Shanxi, China.
Zitieren
APA
Gao, N., Yin, J., Niu, N., Hao, W., Chen, X., & Yang, T. (2025). Comparison of bronchoalveolar lavage fluid mNGS and sputum culture in the clinical application of severe pneumonia. Frontiers in Cellular and Infection Microbiology. https://doi.org/10.3389/fcimb.2025.1593818
Vancouver
Gao N, Yin J, Niu N, Hao W, Chen X, Yang T. Comparison of bronchoalveolar lavage fluid mNGS and sputum culture in the clinical application of severe pneumonia. Frontiers in Cellular and Infection Microbiology. 2025. doi:10.3389/fcimb.2025.1593818
BibTeX
@article{Gao2025,
author = {Gao, Na and Yin, Jianwei and Niu, Na and Hao, Wendong and Chen, Xiushan and Yang, Tian},
title = {Comparison of bronchoalveolar lavage fluid mNGS and sputum culture in the clinical application of severe pneumonia},
journal = {Frontiers in Cellular and Infection Microbiology},
year = {2025},
doi = {10.3389/fcimb.2025.1593818}
}
EUVIMED